previous
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP01133 | 1 | BA_1353 | 30255290 | oligoendopeptidase F, putative | 564 | Drug Target Function | March 2008 | 2H1J | 67.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01245 | 1 | BA_2637 | 30257254 | penicillin-binding protein | 708 | Drug Target Function | March 2008 | 1MWR | 21% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01248 | 1 | BA_3554 | 30258085 | penicillin-binding protein, putative | 377 | Drug Target Function | March 2008 | 2QMI | 22.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00026 | 1 | BA_0399 | 30253934 | tellurium resistance protein, putative | 198 | Virulence | October 2007 | 2QNG | 25.3% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00025 | 1 | BA_0285 | 30253779 | bacitracin ABC transporter, ATP-binding ... | 309 | Virulence | October 2007 | 1OXS | 31.4% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01138 | 1 | BA_4230 | 30258733 | alpha-amylase | 586 | Drug Target Function | March 2008 | 1J0H | 61.3% | Bacillus anthracis | Energy metabolism | Biosynthesis and degradation of polysaccharides | ||||||||||||||||||
| IDP01114 | 1 | BA_4901 | 38502945 | Septation ring formation regulator ezrA | 570 | Conserved Gene / Pathway | March 2008 | Bacillus anthracis | Cellular processes | Cell division | ||||||||||||||||||||
| IDP01258 | 1 | BA_2238 | 30256883 | pbpC | penicillin-binding protein 3 | 661 | Drug Target Function | March 2008 | 1MWR | 34.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01243 | 1 | BA_2345 | 30256982 | penicillin-binding protein 1A | 820 | Drug Target Function | March 2008 | 2OLU | 29.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01208 | 1 | BA_2638 | 30257255 | glycosyl transferase, putative | 387 | Essential Gene | March 2008 | 2IYA | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01165 | 1 | BA_5650 | 30260099 | ABC transporter, ATP-binding protein | 305 | Conserved Gene / Pathway | March 2008 | 1VPL | 30.8% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01103 | 1 | BA_1387 | 47605671 | D-alanine--poly(phosphoribitol) ligase s... | 79 | Drug Target Function | March 2008 | 1DV5 | 45.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01120 | 1 | BA_1194 | 30254907 | oligopeptide ABC transporter, ATP-bindin... | 347 | Conserved Gene / Pathway | March 2008 | 3DHW | 27.1% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP01121 | 1 | BA_1933 | 30256591 | branched-chain amino acid ABC transporte... | 257 | Conserved Gene / Pathway | March 2008 | 1G6H | 31.1% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP00041 | 1 | BA_2409 | 30257040 | chloramphenicol acetyltransferase | 216 | Virulence | October 2007 | 1QCA | 41.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00043 | 1 | BA_2629 | 30257246 | acetyltransferase, CYSE/LACA/LPXA/NODL f... | 210 | Virulence | October 2007 | 1KHR | 59.5% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01174 | 1 | BA_2823 | 30257425 | hypothetical protein BA_2823 | 375 | Drug Target Function | March 2008 | Bacillus anthracis | ||||||||||||||||||||||
| IDP01235 | 1 | BA_5512 | 30259972 | wecC | UDP-N-acetyl-D-mannosamine dehydrogenase... | 427 | Drug Target Function | March 2008 | 2O3J | 28.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01246 | 1 | BA_2648 | 30257265 | penicillin-binding protein | 712 | Drug Target Function | March 2008 | 1QME | 29.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01237 | 1 | BA_5563 | 46396830 | Glucose-specific phosphotransferase enzy... | 165 | Drug Target Function | March 2008 | 1GGR | 46.7% | Bacillus anthracis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | ||||||||||||||||||
| IDP00063 | 1 | BA_4952 | 30259447 | aminoglycoside phosphotransferase family... | 263 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00013 | 1 | BA_3254 | 30257811 | LPXTG-motif cell wall anchor domain prot... | 372 | Drug Target Homolog | October 2007 | 1I84 | 18.3% | Bacillus anthracis | Cell envelope | Other | ||||||||||||||||||
| IDP01139 | 1 | BA_4422 | 30258918 | pepQ-1 | proline dipeptidase | 353 | Drug Target Function | March 2008 | 2ZSG | 45.3% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01250 | 1 | BA_4497 | 30259003 | penicillin-binding protein | 706 | Drug Target Function | March 2008 | 2Z2L | 14.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01142 | 1 | BA_1249 | 30255198 | pabA-2 | para-aminobenzoate synthase glutamine am... | 195 | Drug Target Function | March 2008 | 1QDL | 43.1% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Folic acid | |||||||||||||||||
| IDP00039 | 1 | BA_1960 | 30256617 | aminoglycoside 6-adenylyltransferase, pu... | 290 | Virulence | October 2007 | 2PBE | 37.9% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01150 | 1 | BA_4493 | 34582388 | Phosphate import ATP-binding protein pst... | 271 | Conserved Gene / Pathway | March 2008 | 2OLJ | 32.8% | Bacillus anthracis | Transport and binding proteins | Anions | ||||||||||||||||||
| IDP01257 | 1 | BA_5677 | 30260125 | glycosyl transferase, group 2 family pro... | 267 | Drug Target Function | March 2008 | 3BCV | 11.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01122 | 1 | BA_4045 | 30258552 | ftsZ | cell division protein FtsZ | 386 | Conserved Gene / Pathway | March 2008 | 2VAM | 78.8% | Bacillus anthracis | Cellular processes | Cell division | |||||||||||||||||
| IDP00015 | 1 | BA_4048 | 47605856 | UDP-N-acetylenolpyruvoylglucosamine redu... | 301 | Drug Target Homolog | October 2007 | 1HSK | 39.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01134 | 1 | BA_2001 | 30256654 | intracellular serine protease | 316 | Drug Target Function | March 2008 | 1AK9 | 38% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01234 | 0 | BA_5509 | 30259969 | UDP-N-acetylglucosamine 2-epimerase | 371 | Drug Target Function | March 2008 | 3BEO | 100% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01176 | 1 | BA_2869 | 30257466 | peptidase, putative | 358 | Drug Target Function | March 2008 | 3CE2 | 22.9% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01194 | 1 | BA_1230 | 30255179 | rfbB | dTDP-glucose 4,6-dehydratase | 322 | Conserved Gene / Pathway | March 2008 | 2HUN | 51.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01140 | 1 | BA_4546 | 33301122 | Germination protease precursor (Spore pr... | 368 | Drug Target Function | March 2008 | 1C8B | 71.5% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00044 | 1 | BA_2930 | 30257522 | aacC7 | aminoglycoside N3-acetyltransferase | 265 | Virulence | October 2007 | 3E4F | 100% | Bacillus anthracis | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP01207 | 1 | BA_2610 | 39930865 | D-alanine--D-alanine ligase (D-alanylala... | 304 | Conserved Gene / Pathway | March 2008 | 1E4E | 37.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01137 | 1 | BA_3968 | 47605672 | ATP-dependent protease hslV | 180 | Drug Target Function | March 2008 | 1YYF | 78.9% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01190 | 1 | BA_0872 | 30254622 | N-acetylmuramoyl-L-alanine amidase, fami... | 348 | Drug Target Function | March 2008 | 1YB0 | 16.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01186 | 1 | BA_0298 | 81584380 | Bifunctional purine biosynthesis protein... | 511 | Conserved Gene / Pathway | March 2008 | 1ZCZ | 40.1% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP00017 | 1 | BA_4333 | 81581445 | ribBA | Riboflavin biosynthesis protein ribBA [I... | 397 | Drug Target Homolog | October 2007 | 2BZ0 | 27% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP01151 | 1 | BA_5433 | 30259901 | UDP-N-acetylglucosamine 2-epimerase | 371 | Conserved Gene / Pathway | March 2008 | 3BEO | 99.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01206 | 1 | BA_2446 | 30257076 | N-acetylmuramoyl-L-alanine amidase, fami... | 245 | Conserved Gene / Pathway | March 2008 | 1XOV | 26.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01177 | 1 | BA_4515 | 30259020 | sigA | RNA polymerase sigma-43 factor | 373 | Conserved Gene / Pathway | March 2008 | 1L9Z | 56.8% | Bacillus anthracis | Transcription | Transcription factors | |||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 2QMI | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01112 | 1 | BA_2064 | 30256713 | csaA | chaperone CsaA | 109 | Conserved Gene / Pathway | March 2008 | 2NZH | 72.5% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP01175 | 1 | BA_2825 | 30257427 | peptidase M3 family protein | 548 | Drug Target Function | March 2008 | 3CE2 | 23.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01240 | 1 | BA_1069 | 30254800 | pbpF | penicillin-binding protein 1 | 705 | Drug Target Function | March 2008 | 2OLU | 27.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00061 | 1 | BA_4399 | 30258896 | hemolysin A | 279 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP01199 | 1 | BA_1537 | 67460530 | Chorismate synthase 1 (5-enolpyruvylshik... | 390 | Drug Target Function | March 2008 | 1QXO | 59% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00023 | 1 | BA_5594 | 30260051 | papR | PapR | 48 | Drug Target Homolog | October 2007 | Bacillus anthracis | Cellular processes | Pathogenesis | |||||||||||||||||||
| IDP01157 | 1 | BA_3749 | 60390552 | Phosphonates import ATP-binding protein ... | 257 | Conserved Gene / Pathway | March 2008 | 1F3O | 36.6% | Bacillus anthracis | Transport and binding proteins | Other | ||||||||||||||||||
| IDP01212 | 1 | BA_3024 | 30257611 | glycosyl transferase, group 2 family pro... | 490 | Essential Gene | March 2008 | 3E25 | 9.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01213 | 1 | BA_3251 | 30257808 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 329 | Drug Target Function | March 2008 | 2EBD | 34.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00011 | 1 | BA_2222 | 30256868 | alcohol dehydrogenase, iron-containing | 392 | Drug Target Homolog | October 2007 | 3BFJ | 34.9% | Bacillus anthracis | Energy metabolism | Fermentation | ||||||||||||||||||
| IDP01160 | 1 | BA_4774 | 30259261 | bacitracin ABC transporter, ATP-binding ... | 307 | Conserved Gene / Pathway | March 2008 | 1VPL | 25.7% | Bacillus anthracis | Transport and binding proteins | Other | ||||||||||||||||||
| IDP00010 | 1 | BA_2144 | 30256791 | uroporphyrin-III C-methyltransferase, pu... | 474 | Drug Target Homolog | October 2007 | 1PJQ | 24.1% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Heme, porphyrin, and cobalamin | ||||||||||||||||||
| IDP00008 | 1 | BA_1445 | 30255378 | cysG | uroporphyrin-III C-methyltransferase | 258 | Drug Target Homolog | October 2007 | 1PJQ | 43.8% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Heme, porphyrin, and cobalamin | |||||||||||||||||
| IDP01104 | 1 | BA_4191 | 30258695 | potassium uptake protein, TrkA family | 221 | Conserved Gene / Pathway | March 2008 | 2HMS | 40.3% | Bacillus anthracis | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP01204 | 1 | BA_2274 | 30256914 | glycosyl transferase, group 2 family pro... | 406 | Essential Gene | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01239 | 1 | BA_5670 | 30260118 | glycosyl transferase, group 1 family pro... | 366 | Drug Target Function | March 2008 | 2JJM | 26.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01113 | 1 | BA_0368 | 30253903 | amino acid ABC transporter, ATP-binding ... | 240 | Conserved Gene / Pathway | March 2008 | 2OLJ | 65.4% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP01132 | 1 | BA_4703 | 30259197 | loN2 | ATP-dependent protease LA | 557 | Drug Target Function | March 2008 | 1IQP | 15.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01131 | 1 | BA_5381 | 30259854 | ptsH-2 | phosphocarrier protein HPr | 82 | Conserved Gene / Pathway | March 2008 | 1ZVV | 73.2% | Bacillus anthracis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | |||||||||||||||||
| IDP00037 | 0 | BA_1887 | 30256548 | enterotoxin | 386 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP01181 | 1 | BA_0085 | 38372318 | 2-C-methyl-D-erythritol 2,4-cyclodiphosp... | 158 | Drug Target Function | March 2008 | 3F6M | 64.6% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | ||||||||||||||||||
| IDP01193 | 1 | BA_1185 | 30254899 | fabF | 3-oxoacyl-(acyl-carrier-protein) synthas... | 412 | Drug Target Function | March 2008 | 2GQD | 64.8% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00024 | 1 | BA_0039 | 33516921 | Dimethyladenosine transferase (S-adenosy... | 292 | Virulence | October 2007 | 1QYR | 32.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01164 | 1 | BA_5600 | 30260056 | ABC transporter, ATP-binding protein | 300 | Conserved Gene / Pathway | March 2008 | 2YYZ | 31.3% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01184 | 1 | BA_0267 | 41016866 | 60 kDa chaperonin (Protein Cpn60) (groEL... | 544 | Conserved Gene / Pathway | March 2008 | 1WE3 | 67.1% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01106 | 1 | BA_1846 | 30256116 | msrA-1 | peptide methionine sulfoxide reductase | 178 | Conserved Gene / Pathway | March 2008 | 2GT3 | 36% | Bacillus anthracis | Protein fate | Protein modification and repair | |||||||||||||||||
| IDP01182 | 1 | BA_0250 | 61211622 | Holo-[acyl-carrier-protein] synthase (Ho... | 119 | Drug Target Function | March 2008 | 1F7L | 54.6% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00032 | 1 | BA_1221 | ||||||||||||||||||||||||||||